Treace Medical Concepts, Inc. (TMCI)
After hours:
| Previous close | 15.23 |
| Open | 15.45 |
| Bid | 6.41 x 1000 |
| Ask | 18.65 x 800 |
| Day's range | 15.33 - 16.18 |
| 52-week range | 12.48 - 37.17 |
| Volume | |
| Avg. volume | 229,414 |
| Market cap | 887.226M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Treace Medical Concepts Reports First Quarter 2022 Financial Results
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today reported financial results for the first quarter ended March 31, 2022. Recent Highlights: Revenue of $29.0 million in the first quarter 2022, a 55% increase over the same period last year.Gross margin of 81.0% in the first quarter 2022.F
- GlobeNewswire
Treace Announces Peer-Reviewed Publication of ALIGN3D™ Multicenter Prospective Clinical Data
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, today announced the publication of a peer-reviewed manuscript that details an interim dataset of its ALIGN3D™ multicenter, prospective clinical study in the Journal of Foot & Ankle Surgery. Published interi
- GlobeNewswire
Treace Secures Up to $150 Million in Debt Financing
PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it has entered into a new five-year $150 million loan arrangement with MidCap Financial, comprising up to $120 million in term loans and a $30 million revolving credit facility. Proceeds from the new term loan refinanced the
